GlobeStar Therapeutics Corporation (GSTC)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST
GlobeStar Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 - 2016 |
| Cash & Equivalents | 0 | - | 0.01 | 0.01 | 0.08 | 0.1 | Upgrade
|
| Cash & Short-Term Investments | 0 | - | 0.01 | 0.01 | 0.08 | 0.1 | Upgrade
|
| Cash Growth | - | - | 6.79% | -92.68% | -18.93% | 9.68% | Upgrade
|
| Inventory | - | - | - | - | 0 | 0.04 | Upgrade
|
| Prepaid Expenses | 0.08 | - | 0 | - | 0 | 0 | Upgrade
|
| Total Current Assets | 0.08 | - | 0.01 | 0.01 | 0.09 | 0.14 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | 0 | 0 | Upgrade
|
| Total Assets | 0.08 | - | 0.01 | 0.01 | 0.09 | 0.14 | Upgrade
|
| Accounts Payable | 0.43 | 0.33 | 0.38 | 0.22 | 0.13 | 0.14 | Upgrade
|
| Accrued Expenses | 0.88 | 0.68 | 0.61 | 0.34 | 0.4 | 0.41 | Upgrade
|
| Short-Term Debt | 0.3 | 0.31 | 0.14 | 0.09 | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 0.03 | 0.06 | 0.02 | 0.02 | 0.16 | 0.11 | Upgrade
|
| Other Current Liabilities | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.17 | Upgrade
|
| Total Current Liabilities | 1.71 | 1.43 | 1.2 | 0.73 | 0.75 | 0.83 | Upgrade
|
| Total Liabilities | 1.71 | 1.43 | 1.2 | 0.73 | 0.75 | 0.83 | Upgrade
|
| Common Stock | 1.24 | 1 | 0.72 | 0.56 | 0.44 | 0.17 | Upgrade
|
| Additional Paid-In Capital | 17.98 | 18.02 | 16.58 | 15.23 | 6.12 | 1.23 | Upgrade
|
| Retained Earnings | -21.02 | -20.45 | -18.5 | -17.02 | -7.22 | -6.67 | Upgrade
|
| Comprehensive Income & Other | 0.18 | - | 0.01 | 0.5 | - | - | Upgrade
|
| Total Common Equity | -1.63 | -1.43 | -1.2 | -0.73 | -0.66 | -5.28 | Upgrade
|
| Shareholders' Equity | -1.62 | -1.43 | -1.19 | -0.73 | -0.66 | -0.69 | Upgrade
|
| Total Liabilities & Equity | 0.08 | - | 0.01 | 0.01 | 0.09 | 0.14 | Upgrade
|
| Total Debt | 0.33 | 0.37 | 0.16 | 0.11 | 0.16 | 0.11 | Upgrade
|
| Net Cash (Debt) | -0.33 | -0.37 | -0.15 | -0.1 | -0.07 | -0.01 | Upgrade
|
| Net Cash Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Filing Date Shares Outstanding | 1,241 | 1,026 | 770.36 | 600.37 | 445.49 | 210.3 | Upgrade
|
| Total Common Shares Outstanding | 1,241 | 996.12 | 722.33 | 561.5 | 436.22 | 170.47 | Upgrade
|
| Working Capital | -1.62 | -1.43 | -1.19 | -0.73 | -0.66 | -0.69 | Upgrade
|
| Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.03 | Upgrade
|
| Tangible Book Value | -1.63 | -1.43 | -1.2 | -0.73 | -0.66 | -5.28 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.